Article

Lymphocyte Antigen 9 as a potential immunotherapeutic target and a new prognostic biomarker for lung adenocarcinoma

2022-03-10

Abstract excerpt

<h4>Background: </h4> Lymphocyte Antigen 9 (LY9) participates in the development of several tumors and diseases. However, it has not been reported yet in lung adenocarcinoma (LUAD). <h4>Methods: </h4> First, we retrieved the pan-cancer transcriptomic and clinical data from the UCSC official website and performed LY9 differential expression analysis. Then, we used the Kaplan-Meier Plotter and GEPIA databases to per...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1b880898-bbbb-5d7f-8164-d7c4115595d2
DOI: 10.21203/rs.3.rs-1425442/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lymphocyte Antigen 9 as a potential immunotherapeutic target and a new prognostic biomarker for lung adenocarcinomaDOI 10.21203/rs.3.rs-1425442/v1Read

NEIL3 may act as a potential prognostic biomarker for lung adenocarcinomaSemantic proximity Read

Linc00996 is a favorable prognostic factor in LUAD: Results from bioinformatics analysis and experimental validationSemantic proximity Read

Construction of NEIL3 as a Prognostic Biomarker and Co-expressed Prognostic Signature in Lung AdenocarcinomaSemantic proximity Read

Comprehensive Analysis of the Prognostic Values and Immune Implication of ESYT3 in Lung AdenocarcinomaSemantic proximity Read

Comprehensive analysis of the prognostic values and immune implication of ESYT3 in lung adenocarcinomaSemantic proximity Read

EXO1 is a key gene for lung-resident memory T cells and has diagnostic and predictive values for lung adenocarcinoma.Semantic proximity Read

Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinomaSemantic proximity Read

Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinomaSemantic proximity Read

B7-H4 is increased in lung adenocarcinoma harboring EGFR-activating mutations and contributes to immunosuppression.Semantic proximity Read

Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer TypesSemantic proximity Read

Prognostic and immune infiltrative biomarkers of CENPO in pan- cancer and its relationship with lung adenocarcinoma cell proliferation and metastasisSemantic proximity Read

MiRNA-625-3p as novel biomarker promotes cell proliferation and metastasis of lung adenocarcinoma by targeting KLF9Semantic proximity Read